Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bai-Rong Xia

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cancer Cell International|December 24, 2019
Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid modelChang Yang, Bai-Rong Xia, Wei-Lin Jin, et al.
Frontiers in Oncology|December 25, 2018
Curaxin CBL0137 Exerts Anticancer Activity via Diverse MechanismsMing-Zhu Jin, Bai-Rong Xia, Yu Xu, et al.
Frontiers in Oncology|December 5, 2019
Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human CancersShi-Jia Jin, Ming-Zhu Jin, Bai-Rong Xia, et al.
Frontiers in Oncology|June 27, 2022
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer TherapyXiao-Yu Li, Ya-Nan Pi, Yao Chen, et al.
Frontiers in Immunology|April 25, 2022
Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic PotentialYa-Nan Pi, Wen-Cai Qi, Bai-Rong Xia, et al.
Biochemical Pharmacology|March 1, 2021
Exosomes: Powerful weapon for cancer nano-immunoengineeringYa-Nan Pi, Bai-Rong Xia, Ming-Zhu Jin, et al.
Frontiers in Immunology|July 23, 2021
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic PotentialYa-Nan Pi, Wen-Cai Qi, Bai-Rong Xia, et al.
Frontiers in Pharmacology|April 10, 2023
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancerXu Huang, Xiao-Yu Li, Wu-Lin Shan, et al.
Cancer Cell International|October 16, 2020
E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinomaChang Yang, Zhao-Cong Zhang, Tian-Bo Liu, et al.
Frontiers in Immunology|October 30, 2020
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and NeoadjuvantChang Yang, Bai-Rong Xia, Zhao-Cong Zhang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cancer Cell International|December 24, 2019
Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid modelChang Yang, Bai-Rong Xia, Wei-Lin Jin, et al.
Frontiers in Oncology|December 25, 2018
Curaxin CBL0137 Exerts Anticancer Activity via Diverse MechanismsMing-Zhu Jin, Bai-Rong Xia, Yu Xu, et al.
Frontiers in Oncology|December 5, 2019
Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human CancersShi-Jia Jin, Ming-Zhu Jin, Bai-Rong Xia, et al.
Frontiers in Oncology|June 27, 2022
Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer TherapyXiao-Yu Li, Ya-Nan Pi, Yao Chen, et al.
Frontiers in Immunology|April 25, 2022
Corrigendum: Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic PotentialYa-Nan Pi, Wen-Cai Qi, Bai-Rong Xia, et al.
Biochemical Pharmacology|March 1, 2021
Exosomes: Powerful weapon for cancer nano-immunoengineeringYa-Nan Pi, Bai-Rong Xia, Ming-Zhu Jin, et al.
Frontiers in Immunology|July 23, 2021
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic PotentialYa-Nan Pi, Wen-Cai Qi, Bai-Rong Xia, et al.
Frontiers in Pharmacology|April 10, 2023
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancerXu Huang, Xiao-Yu Li, Wu-Lin Shan, et al.
Cancer Cell International|October 16, 2020
E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinomaChang Yang, Zhao-Cong Zhang, Tian-Bo Liu, et al.
Frontiers in Immunology|October 30, 2020
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and NeoadjuvantChang Yang, Bai-Rong Xia, Zhao-Cong Zhang, et al.
Pageof 2